These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals. Balasko A; Keynan Y HIV Med; 2019 Jan; 20(1):1-10. PubMed ID: 30362282 [TBL] [Abstract][Full Text] [Related]
7. Skin and mucosal manifestations of immune reconstitution inflammatory syndrome in people living with HIV: a review. Górecka A; Majewski S; Szymańska E; Walecka I Int J Dermatol; 2024 Jul; 63(7):852-857. PubMed ID: 38426349 [TBL] [Abstract][Full Text] [Related]
8. Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274. Giacoia-Gripp CBW; Cazote ADS; da Silva TP; Sant'Anna FM; Schmaltz CAS; Brum TS; de Matos JA; Silva J; Benjamin A; Pilotto JH; Rolla VC; Morgado MG; Scott-Algara D Front Immunol; 2019; 10():1800. PubMed ID: 31456797 [TBL] [Abstract][Full Text] [Related]
9. HIV & immune reconstitution inflammatory syndrome (IRIS). Sharma SK; Soneja M Indian J Med Res; 2011 Dec; 134(6):866-77. PubMed ID: 22310819 [TBL] [Abstract][Full Text] [Related]
10. A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. Mori S; Levin P Int J STD AIDS; 2009 Jul; 20(7):447-52. PubMed ID: 19541884 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients. da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142 [TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170 [TBL] [Abstract][Full Text] [Related]